Year |
Citation |
Score |
2023 |
Groenweghe E, Swensson L, Winans KD, Griffin P, Haddad MB, Brostrom RJ, Tuckey D, Lam CK, Armitige LY, Seaworth BJ, Corriveau EA. Outbreak of Multidrug-Resistant Tuberculosis - Kansas, 2021-2022. Mmwr. Morbidity and Mortality Weekly Report. 72: 957-960. PMID 37651293 DOI: 10.15585/mmwr.mm7235a4 |
0.374 |
|
2018 |
Mase A, Ryan S, Mader G, Alvarez A, Armitige L, Chen L, McSherry G, Wilson J, Mase S, Banerjee R. Pediatric tuberculosis consultations across 5 CDC regional tuberculosis training and medical consultation Centers. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 11: 23-27. PMID 31720388 DOI: 10.1016/J.Jctube.2018.04.004 |
0.374 |
|
2017 |
Marks SM, Hirsch-Moverman Y, Seaworth B, Salcedo K, Graviss EA, Armstrong L, Armitige L, Flood J, Mase S. Outcomes and costs of out-patient MDR-TB care in the USA. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 21: 477-478. PMID 28284273 DOI: 10.5588/Ijtld.17.0009 |
0.324 |
|
2017 |
Kizilbash Q, Jost K, Armitige L, Griffith DE, Dunbar D, Seaworth B. Reduction in Nontuberculous Mycobacteria at a Tuberculosis Hospital Following a Quality Assurance Intervention Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.1802 |
0.314 |
|
2016 |
Arora R, Armitige L, Wanger A, Hunter RL, Hwang SA. Association of pellicle growth morphological characteristics and clinical presentation of Mycobacterium tuberculosis isolates. Tuberculosis (Edinburgh, Scotland). PMID 27742461 DOI: 10.1016/J.Tube.2016.09.015 |
0.596 |
|
2016 |
Marks SM, Hirsch-Moverman Y, Salcedo K, Graviss EA, Oh P, Seaworth B, Flood J, Armstrong L, Armitige L, Mase S. Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 20: 435-41. PMID 26970150 DOI: 10.5588/Ijtld.15.0575 |
0.459 |
|
2015 |
Banerjee R, Ryan S, Mader G, Alvarez A, Armitige L, Chen L, Mcsherry GD, Wilson J, Mase S. Pediatric Tuberculosis Consultations Across 5 Centers for Disease Control and Prevention Regional Tuberculosis Training and Medical Consultation Centers Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.438 |
0.352 |
|
2014 |
Marks SM, Flood J, Seaworth B, Hirsch-Moverman Y, Armstrong L, Mase S, Salcedo K, Oh P, Graviss EA, Colson PW, Armitige L, Revuelta M, Sheeran K. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007. Emerging Infectious Diseases. 20: 812-21. PMID 24751166 DOI: 10.3201/Eid2005.131037 |
0.493 |
|
2014 |
Seaworth BJ, Armitige LY, Aronson NE, Hoft DF, Fleenor ME, Gardner AF, Harris DA, Stricof RL, Nardell EA. Multidrug-resistant tuberculosis. Recommendations for reducing risk during travel for healthcare and humanitarian work. Annals of the American Thoracic Society. 11: 286-95. PMID 24673692 DOI: 10.1513/Annalsats.201309-312Ps |
0.426 |
|
2012 |
Saikolappan S, Estrella J, Sasindran SJ, Khan A, Armitige LY, Jagannath C, Dhandayuthapani S. The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophages. Plos One. 7: e36198. PMID 22574140 DOI: 10.1371/Journal.Pone.0036198 |
0.402 |
|
2011 |
Armitige L, Wallace C. Tuberculosis in Texas 2011--victories and challenges. Tuberculosis. 91. PMID 22137297 DOI: 10.1016/J.Tube.2011.10.002 |
0.365 |
|
2011 |
Welsh KJ, Skrobarcek KA, Abbott AN, Lewis CT, Kruzel MC, Lewis EM, Gardiner JM, Mohr JF, Armitige LY, Wanger A. Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycin. Journal of Clinical Microbiology. 49: 3669-72. PMID 21865420 DOI: 10.1128/Jcm.05287-11 |
0.617 |
|
2011 |
Kruzel MC, Lewis CT, Welsh KJ, Lewis EM, Dundas NE, Mohr JF, Armitige LY, Wanger A. Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology. 49: 2272-3. PMID 21450951 DOI: 10.1128/Jcm.02215-10 |
0.599 |
|
2011 |
Welsh KJ, Skrobarcek KA, Abbott AN, Lewis CT, Kruzel MC, Lewis EM, Armitige LY, Wanger A. 126 Predictors of Relapse of Methicillin-Resistant Staphylococcus Aureus Bacteremia After Vancomycin Treatment Annals of Emergency Medicine. 58. DOI: 10.1016/J.Annemergmed.2011.06.153 |
0.623 |
|
2010 |
Welsh KJ, Abbott AN, Lewis EM, Gardiner JM, Kruzel MC, Lewis CT, Mohr JF, Wanger A, Armitige LY. Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin. Journal of Clinical Microbiology. 48: 894-9. PMID 20089758 DOI: 10.1128/Jcm.01949-09 |
0.611 |
|
2009 |
Wallace C, Armitige L. Tuberculosis in Texas 2008. Tuberculosis. 89. PMID 20006301 DOI: 10.1016/S1472-9792(09)70003-4 |
0.375 |
|
2009 |
Hunter RL, Armitige L, Jagannath C, Actor JK. TB research at UT-Houston--a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis. Tuberculosis (Edinburgh, Scotland). 89: S18-25. PMID 20006299 DOI: 10.1016/S1472-9792(09)70007-1 |
0.441 |
|
2008 |
Katti MK, Dai G, Armitige LY, Rivera Marrero C, Daniel S, Singh CR, Lindsey DR, Dhandayuthapani S, Hunter RL, Jagannath C. The Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells. Cellular Microbiology. 10: 1286-303. PMID 18248626 DOI: 10.1111/J.1462-5822.2008.01126.X |
0.367 |
|
2006 |
Singh CR, Moulton RA, Armitige LY, Bidani A, Snuggs M, Dhandayuthapani S, Hunter RL, Jagannath C. Processing and presentation of a mycobacterial antigen 85B epitope by murine macrophages is dependent on the phagosomal acquisition of vacuolar proton ATPase and in situ activation of cathepsin D. Journal of Immunology (Baltimore, Md. : 1950). 177: 3250-9. PMID 16920965 DOI: 10.4049/Jimmunol.177.5.3250 |
0.32 |
|
2004 |
Copenhaver RH, Sepulveda E, Armitige LY, Actor JK, Wanger A, Norris SJ, Hunter RL, Jagannath C. A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential. Infection and Immunity. 72: 7084-95. PMID 15557632 DOI: 10.1128/Iai.72.12.7084-7095.2004 |
0.599 |
|
2003 |
Smith KC, Armitige L, Wanger A. A review of tuberculosis: reflections on the past, present and future of a global epidemic disease. Expert Review of Anti-Infective Therapy. 1: 483-491. PMID 15482144 DOI: 10.1586/14787210.1.3.483 |
0.608 |
|
2000 |
Armitige LY, Jagannath C, Wanger AR, Norris SJ. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infection and Immunity. 68: 767-78. PMID 10639445 DOI: 10.1128/Iai.68.2.767-778.2000 |
0.594 |
|
Show low-probability matches. |